Similar articles

• Intralesional Bleomycin for Warts: Patient Satisfaction and Treatment Outcomes.

  Kruter L, Saggar V, Akhavan A, Patel P, Umanoff N, Viola KV, Stebbins W, Smith E, Akhavan A, Cohen JV, Cohen SR. Kruter L, et al. J Cutan Med Surg. 2015 Sep-Oct;19(5):470-6. doi: 10.1177/1203475415576860. Epub 2015 Mar 18. J Cutan Med Surg. 2015. PMID: 26271964
• A new method of intralesional bleomycin therapy in the treatment of recalcitrant warts.

  Munn SE, Higgins E, Marshall M, Clement M. Munn SE, et al. Br J Dermatol. 1996 Dec;135(6):969-71. doi: 10.1046/j.1365-2133.1996.d01-1104.x. Br J Dermatol. 1996. PMID: 8977721
• [Bleomycin prick in therapy-resistant verruca vulgaris].

  Werfel S, Wolff H. Werfel S, et al. Hautarzt. 2001 Jul;52(7):638-41. doi: 10.1007/s001050170105. Hautarzt. 2001. PMID: 11475646 German.
• [Perhydrol treatment experience with warts].

  Gusakov NI, Korostylev AF. Gusakov NI, et al. Vestn Dermatol Venerol. 1980 Oct;(10):56-7. Vestn Dermatol Venerol. 1980. PMID: 7003967 Review. Russian. No abstract available.
• Lymphangitis as a complication of intralesional bleomycin therapy.

  Allen AL, Fosko SW. Allen AL, et al. J Am Acad Dermatol. 1998 Aug;39(2 Pt 1):295-7. doi: 10.1016/s0190-9622(98)70097-0. J Am Acad Dermatol. 1998. PMID: 9704855 Review. No abstract available.